<DOC>
	<DOC>NCT03001141</DOC>
	<brief_summary>This is a prospective, multicenter, non-randomized registry/observational study. The study will enroll up to 200 patients with successful St. Jude Medical (SJM) Cardiac Resynchronization Therapy (CRT) MP device implant from up to 10 centers.</brief_summary>
	<brief_title>Study Protocol/ Registry of MultiPointâ„¢ Pacing in Brazil</brief_title>
	<detailed_description>Any patient receiving a market-approved SJM Quadra Assura MP (CRT-D) or newer model quadripolar device with MPP capability and who meets the inclusion criteria and none of the exclusion criteria is eligible for enrollment in the study. Patients will be followed for 12 months after implant. Data will be collected after device implant (up to 30 days after successful implant), at 3, 6 and 12 months post-implant and during unscheduled visits.</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Patient willing and able to sign Informed Consent Form Any patient receiving a marketapproved SJM Quadra Assura MP (CRTD) or newer model quadripolar device with MPP capability Is likely to undergo a heart transplantation within 12 months Is less than 18 years old Is pregnant or is planning to get pregnant during the study Is currently taking part in a Clinical Trial with an active treatment group Life expectancy is under 6 months</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>MultiPoint Pacing</keyword>
	<keyword>Heart Failure</keyword>
	<keyword>Cardiac Resynchronization Therapy</keyword>
	<keyword>Quadripolar pacing</keyword>
</DOC>